BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17763263)

  • 1. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive efficacy and side effects of Implanon.
    Gezginc K; Balci O; Karatayli R; Colakoglu MC
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Implanon on menstrual bleeding patterns.
    Mansour D; Korver T; Marintcheva-Petrova M; Fraser IS
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():13-28. PubMed ID: 18330814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels.
    Dilbaz B; Ozdegirmenci O; Caliskan E; Dilbaz S; Haberal A
    Contraception; 2010 Jun; 81(6):510-4. PubMed ID: 20472118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year study of Implanon on the adverse events and discontinuation.
    Chaovisitsaree S; Piyamongkol W; Pongsatha S; Morakote N; Noium S; Soonthornlimsiri N
    J Med Assoc Thai; 2005 Mar; 88(3):314-7. PubMed ID: 15962637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of early implant discontinuation among low-income women.
    Kalmuss D; Davidson AR; Cushman LF; Heartwell S; Rulin M
    Fam Plann Perspect; 1996; 28(6):256-60. PubMed ID: 8959415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital.
    Laphikanont W; Taneepanichskul S
    J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
    Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
    Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australian women's experience with Implanon.
    Weisberg E; Fraser I
    Aust Fam Physician; 2005 Aug; 34(8):694-6. PubMed ID: 16113711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
    Weisberg E; Hickey M; Palmer D; O'Connor V; Salamonsen LA; Findlay JK; Fraser IS
    Hum Reprod; 2006 Jan; 21(1):295-302. PubMed ID: 16284061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insertion problems, removal problems, and contraception failures with Implanon].
    Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F; Llabres S; Autret-Leca E;
    Gynecol Obstet Fertil; 2005 Dec; 33(12):986-90. PubMed ID: 16321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contraceptive implant.
    Hohmann H; Creinin MD
    Clin Obstet Gynecol; 2007 Dec; 50(4):907-17. PubMed ID: 17982333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.